{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fdocs-who-lift.simplecast.com%2Fepisodes%2Fsemaglutide-and-blindness-qz0Dy8wi","width":444,"version":"1.0","type":"rich","title":"Semaglutide and Blindness","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/221baa1a-131b-4cc0-92ab-97034c77fad0/d9b0e3cd-db46-4dbf-95ca-8eddbec923dd/20609148-1645971404309-bef6736cf05db.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/b1e14d9d-6b88-4a66-9a50-d2ff8da08b43\" height=\"200\" width=\"100%\" title=\"Semaglutide and Blindness\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Drs. Karl and Spencer discuss with ophthalmologist Dr. Brugger about the recent study showing a relationship between semaglutide and NAION (nonarteritic anterior ischemic optic neuropathy)."}